The Medical Consensus
Major medical authorities advise against cannabis use during pregnancy and breastfeeding. The position is consistent across the major bodies that issue guidance on prenatal and infant health.
American College of Obstetricians and Gynecologists (ACOG). Recommends discontinuation of cannabis use before conception, throughout pregnancy, and during breastfeeding. ACOG notes that cannabinoids including THC and CBD cross the placenta and pass into breast milk, and that the safety data needed to clear cannabis for use during these windows does not exist.
Centers for Disease Control and Prevention (CDC). Identifies cannabis use during pregnancy as a public health concern associated with adverse outcomes for the developing fetus and infant. CDC guidance is consistent with the ACOG position.
U.S. Food and Drug Administration (FDA). Has issued public communications warning consumers not to use cannabis, hemp-derived CBD, or any cannabinoid product during pregnancy or breastfeeding. The FDA position covers both intoxicating cannabinoids (THC) and non-intoxicating cannabinoids (CBD, CBG, CBN).
American Academy of Pediatrics (AAP). Recommends against cannabis use during breastfeeding given the documented transfer of cannabinoids into breast milk and the absence of safety data for the breastfeeding infant.
New York State Department of Health. Aligns with the federal medical authority position. NYS-specific guidance is consistent with ACOG and CDC recommendations.
The consistency across these authorities reflects shared concern about the developmental effects of prenatal and early-life cannabis exposure plus the precautionary principle that governs medical guidance for pregnancy. In the absence of safety data showing cannabis is safe during these windows, the recommendation is avoidance.
Why The Concern
Cannabinoids cross the placenta. THC, CBD, and other cannabinoids in maternal circulation reach the fetus through the placental circulation. The fetal endocannabinoid system plays roles in early brain development, neuron migration, and the formation of neural connections. Disrupting that system during a critical developmental window is the concern that drives the medical recommendation.
The concerns the medical authorities cite fall into a few areas.
Lower birth weight. The authorities link prenatal cannabis exposure with reduced birth weight, which can carry a higher risk of complications in the newborn period.
Preterm birth. Cannabis use during pregnancy is cited as a possible factor in earlier delivery.
Neurodevelopmental outcomes. Authorities raise concerns about attention, cognition, and behavior differences later in childhood. Cause and effect is hard to pin down here, because cannabis use during pregnancy often overlaps with other factors that also affect outcomes, which is one reason the guidance stays cautious rather than certain.
Breast milk transfer. Cannabinoids appear in breast milk after consumption, and because they are fat-soluble they can linger. A nursing infant takes in that exposure during a period of rapid brain development.
The authorities are upfront that the evidence is stronger for some of these than others. The recommendation to avoid cannabis reflects a precautionary stance given that data showing it is safe in pregnancy does not exist.
Why Some Pregnant Individuals Use Cannabis Anyway
A meaningful minority of pregnant individuals use cannabis during pregnancy. Survey data and clinical observation document several reasons.
Severe nausea and vomiting (hyperemesis gravidarum). Severe pregnancy-related nausea that does not respond to standard antiemetic medications like ondansetron or doxylamine-pyridoxine. Some patients find cannabis helpful when other options fail. The condition can be debilitating and the cannabis-versus-alternative-treatment conversation is worth having with the obstetric provider rather than as a self-managed choice.
Anxiety and stress. Pregnancy can intensify anxiety, depression, or pre-existing mental health conditions. Some patients use cannabis as an alternative to anti-anxiety medications that carry their own pregnancy considerations (benzodiazepines, SSRIs in certain trimesters). The clinical answer is not always obvious because every treatment option in pregnancy involves a benefit-versus-risk calculation; the medical authority position is that cannabis is not the preferred option.
Chronic pain. Patients with pre-pregnancy chronic pain conditions may continue cannabis use during pregnancy. The pain management conversation during pregnancy involves several options and the obstetric provider is the right interlocutor.
Sleep difficulties. Some patients use cannabis for pregnancy-related insomnia, which is common in the third trimester. Non-pharmacological sleep strategies and provider-recommended options are the medical authority preference.
Lack of awareness. Some patients are unaware of the medical authority recommendations or have heard mixed messages. The medical authority position is clear and consistent.
The medical authority position across these use cases is that other treatment options should be tried first, that cannabis should be avoided when possible, and that any cannabis use during pregnancy should be discussed with the obstetric provider rather than self-managed. The conversation between patient and provider is the right place for the specific calculation that fits a specific case.
Talk To A Provider, Not A Budtender
The Alchemy is a licensed adult-use dispensary, not a medical provider, and we do not give medical advice about cannabis use during pregnancy or breastfeeding. If you have questions, the right person to ask is your obstetric or midwifery provider, who can account for your specific situation. The resources listed below are also a good starting point.
Resources For Pregnant Individuals
Your obstetric provider. The most important resource for any pregnancy-related cannabis question. The provider knows your specific medical situation, your medication list, your trimester, your prior pregnancy history, and the specific clinical considerations that apply to your case. The conversation is confidential under standard medical privacy rules.
MotherToBaby. A non-profit resource for evidence-based information about exposures during pregnancy and breastfeeding, run by the Organization of Teratology Information Specialists. Free counseling by phone and chat with trained teratology information specialists. mothertobaby.org
NYS Medical Cannabis Program. For patients with serious medical conditions for whom cannabis is being considered, the NYS medical program offers consultation with registered practitioners who can advise on risks and benefits in specific medical contexts. Medical cannabis patients with pregnancy considerations should discuss the situation with the medical practitioner who issued the certification.
NYC Department of Health and Mental Hygiene. Local resources for pregnancy support, prenatal care, and substance use counseling. The Department's pregnancy and parenting hub provides a starting point.
Poison Control 1-800-222-1222. For accidental cannabis exposure during pregnancy or for any questions about cannabis exposure in pregnancy or breastfeeding. The national Poison Help line connects you to your regional center and is staffed around the clock.
SAMHSA National Helpline 1-800-662-4357. Free, confidential, 24-hour treatment referral and information service for substance use questions.
After Pregnancy
For postpartum individuals considering returning to cannabis use, the breastfeeding consideration extends the medical authority recommendation for the duration of breastfeeding. Cannabinoids appear in breast milk for hours to days after consumption and the cannabinoids are fat-soluble, which extends their presence in breast tissue. The breastfeeding infant receives the exposure.
Once breastfeeding ends or if the individual is not breastfeeding, the medical authority recommendation no longer applies in the same way. Postpartum individuals can resume adult-use cannabis on the same legal basis as any adult 21 and over.
Postpartum mood concerns, including postpartum depression and postpartum anxiety, remain a medical conversation worth having with an obstetric provider or a mental health professional. If and when you do return to cannabis, a budtender can walk you through the live menu, and starting low is sensible.
FAQs
Is CBD safe during pregnancy?
The FDA recommends against any cannabinoid use during pregnancy, including CBD. CBD crosses the placenta and the breastfeeding implications are similar to other cannabinoids. The position covers both hemp-derived CBD products and cannabis-derived CBD products. Consult your obstetric provider for personalized guidance.
What if I used cannabis before knowing I was pregnant?
Discuss the timing and use pattern with your obstetric provider. Many pregnancies proceed normally even with early exposure before pregnancy was known. Your provider can address specific concerns about your case, monitor as appropriate, and provide guidance going forward. The conversation is confidential.
Can I use cannabis to manage morning sickness or hyperemesis gravidarum?
Medical authorities recommend other antiemetics first (vitamin B6, doxylamine, ondansetron, IV fluids for severe cases). Some patients with severe refractory hyperemesis discuss cannabis with their provider as a last-resort option after standard treatments have failed. Self-managing severe pregnancy nausea with cannabis without medical consultation is not recommended; severe hyperemesis is a serious condition that benefits from clinical care.
How long should I abstain before getting pregnant?
Medical authorities recommend cannabis discontinuation before conception. The specific timeframe varies by individual circumstance; ask your obstetric or fertility provider for the recommendation that fits your situation. Both individuals contributing to a conception may have reasons to consider their cannabis use; the conversation is worth having before trying to conceive.
What if my partner uses cannabis around me during pregnancy?
Secondhand cannabis smoke exposure during pregnancy is also a concern, similar to secondhand tobacco smoke. Minimize cannabis smoke and vapor exposure in shared living spaces during pregnancy. Edibles or other non-combustible formats avoid the secondhand exposure issue but the partner-pregnancy support conversation is still worth having.
Will a dispensary advise me about cannabis use during pregnancy?
No. A dispensary is a retailer, not a medical provider, and cannot give clinical guidance on pregnancy. Bring pregnancy-related cannabis questions to your obstetric provider or to the resources listed above.
Why do medical authorities recommend against cannabis in pregnancy?
Because cannabinoids reach the fetus and the data needed to show cannabis is safe during pregnancy does not exist. The concerns the authorities raise include lower birth weight and earlier delivery, with more caution around longer-term effects on the child. Given the uncertainty, the guidance is to avoid use.
Can I use cannabis topicals (creams, balms) during pregnancy?
Topical absorption of cannabinoids through intact skin is generally limited. The FDA recommendation still covers any cannabinoid product including topicals because absorption can vary and the safety data for pregnancy-specific use is absent. Consult your obstetric provider before using any cannabinoid product including topicals.
Where can I get free, confidential help if I am struggling with cannabis use during pregnancy?
MotherToBaby (mothertobaby.org), SAMHSA National Helpline at 1-800-662-4357, NYC Department of Health and Mental Hygiene resources, and your obstetric provider are all confidential resources. The conversation does not generate a report to child welfare authorities except in specific circumstances that vary by case.
The Alchemy Editors
Field notes from the counter at Chelsea + Flatiron.
Written by our procurement and budtender team. Every claim verified against NYS OCM regulations and current shelf inventory. Updated as the menu rotates.
Continue reading
Next from The Alchemy Journal.
Does Cannabis Show Up On A Drug Test
Yes. Cannabis can show up on a drug test for a while after you use it. How long depends on the test, how often you use, your body, and your metabolism, so there is no single number that fits everyone. This page covers what these tests actually look for, why detection windows vary so much, and how the law treats off-duty cannabis use for many workers in New York.
Cannabis And Driving
Driving while impaired by cannabis is illegal in New York, and the penalties are serious. New York treats drug impairment behind the wheel a lot like alcohol impairment, but it is detected and prosecuted differently. Here is what the law actually says, plus some plain advice if cannabis is part of your night.
How To Read A Cannabis Certificate Of Analysis
Every cannabis product sold at a New York State licensed dispensary carries a Certificate of Analysis (COA) from a state-certified independent testing laboratory. The COA documents what the product contains and confirms that it passed safety screening. Customers access the COA by scanning the QR code on the package. This guide explains how to read each section.